1. Chuchalin A.G., Khaltaev N., Antonov N.S. et al. Chronic respiratory diseases and risk factors in 12 regions of the Russian Federation. Int. J. Chron. Obstruct. Pulm. Dis. 2014; 9 (1): 963-974.
2. Chuchalin A.G., Aisanov Z.R., Avdeev S.N. i dr. Rossiiskoe respiratornoe obshchestvo. Federal'nye klinicheskie rekomendatsii po diagnostike i lecheniyu khronicheskoi obstruktivnoi bolezni legkikh: metodicheskie rekomendatsii. Pul'monologiya. 2014; 3: 15-36.
3. Krysanov I.S. Analiz stoimosti khronicheskoi obstruktivnoi bolezni legkikh v Rossiiskoi Federatsii. Kachestvennaya klinicheskaya praktika. 2014; 2: 51-56.
4. Gibson G.J., Loddenkemper R., Sibille Y., Lundback B. The European Lung White Book. Sheffield: European Respiratory Society; 2013 Available from: http://www.erswhitebook.org/files/public/Chapters/13_COPD.pdf (Accessed Feb. 14, 2015).
5. The American Lung Association. Epidemiology and statistics unit. Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and mortality 2013. Available from: http://www.lung.org/finding-cures/our-research/trend-reports/copd-trend-report.pdf (Accessed Feb. 11, 2015).
6. Perera P.N., Armstrong E.P., Sherrill D.L. et al. Acute exacerbations of COPD in the United States: Inpatient burden and predictors of costs and mortality. Int. J. Chron. Obstruct. Pulm. Dis. 2012; 9 (2): 131-141.
7. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Obstructive Lung Disease; 2015. Available from: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015.pdf (Accessed Feb. 4, 2015).
8. Chuchalin A.G., red. Respiratornaya meditsina. M.: GEOTAR-Media; 2007. T. 1.
9. Mannino D.M., Higuchi K., Yu T.-C. et al. Economic burden of chronic obstructive pulmonary disease by presence of comorbidities. Chest. Published online Feb. 12, 2015. 10.1378/chest.14-2434. Available from: http://journal.publications.chestnet.org/article.aspx?articleID=2119206 (Accessed Feb. 23, 2015).
10. Fabbri L.M., Luppi F., Begh#é B et al. Complex chronic comorbidities of COPD Eur. Respir. J. 2008; 31: 204-212.
11. Vorob'ev P.A., red. Kliniko-ekonomicheskii analiz M.: N'yudiamed; 2008.
12. Savel'ev V.S., Gel'fand B.R., Yakovlev S.V. Strategiya i taktika primeneniya antimikrobnykh sredstv v lechebnykh uchrezhdeniyakh Rossii: Rossiiskie natsional'nye rekomendatsii M.: OOO «Kompaniya BORGES»; 2012.
13. Stefan M.S., Rothberg M.B., Shieh M.S. et al. Association between antibiotic treatment and outcomes in patients hospitalized with acute exacerbation of COPD treated with systemic steroids. Chest. 2013; 143 (1): 82-90.
14. Avdeev S.N. Khronicheskaya obstruktivnaya bolezn' legkikh: obostreniya. Pul'monologiya. 2013; 3: 5-19.
15. Yakovlev S.V., Sidorenko S.V., Rafal'skii V.V., Spichak T.V. Strategiya i taktika ratsional'nogo primeneniya antimikrobnykh sredstv v ambulatornoi praktike: Rossiiskie prakticheskie rekomendatsii. M.: Presto; 2014.
16. Kahn S.R., Lim W., Dunn A.S. et al. Prevention of VTE in nonsurgical patients. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141 (2): 195-226.
17. Belousov D.Yu., Afanas'eva E.V., Kirienko A.I. i dr. Farmakoepidemiologicheskaya i kliniko-ekonomicheskaya otsenka profilaktiki venoznykh tromboembolicheskikh oslozhnenii (real'naya praktika naznachenii). Kachestvennaya klinicheskaya praktika. 2013; 2: 2-17.
18. Stepashkin K.N., Petrova M.M., Demko I.V. Vliyanie komorbidnoi kardiovaskulyarnoi patologii na kachestvo zhizni bol'nykh khronicheskoi obstruktivnoi bolezn'yu legkikh. Sibirskoe meditsinskoe obozrenie. 2013; 4: 66-69.
19. Korreia L.L., Lebedev T.Yu., Efremova O.A. i dr. Problema polimorbidnosti pri sochetanii khronicheskoi obstruktivnoi bolezni legkikh i nekotorykh serdechno-sosudistykh zabolevanii. Nauchnye vedomosti BelGU. Seriya: Meditsina. Farmatsiya. 2013 (vyp. 21); 4 (147): 12-17.
20. Au D.H., Bryson C.L., Fan V.S. et al. Beta-blockers as single-agent therapy for hypertension and the risk of mortality among patient with chronic obstructive pulmonary disease. Am. J. Med. 2004; 117 (12): 925-931.